CPT code 93895 represents a diagnostic ultrasound procedure that measures the thickness of the intima and media layers of the carotid artery (carotid intima-media thickness, or CIMT). This imaging measure is used to track atherosclerotic plaque build-up and is clinically relevant for assessing risk of cardiovascular and cerebrovascular disease at a population level. The code matters nationally as clinicians and payers evaluate the role of imaging biomarkers in preventive cardiology and stroke risk stratification.

Key payers covered in this discussion include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for CPT code 93895, including the service type and typical sites of service, plus what to expect when reviewing payer coverage patterns. The publication will outline benchmark considerations, common modifier usage (as provided), and areas where data was not provided. It also highlights the procedural purpose — monitoring arterial wall changes due to fatty deposition — so clinicians, administrators, and policy analysts can understand the code's clinical intent and operational settings.

This national-level summary is intended to inform revenue cycle teams, coding professionals, and policy analysts about the clinical function and typical utilization settings for CPT code 93895, and to frame follow-up review of payer-specific coverage policies and reimbursement benchmarks.